Om Megashree Pharmaceuticals Limited will offer 1,476,000 unit IPO shares at a face value of Rs. 100 starting from 27th Falgun, 2081. The deadline for this offering is set for the 3rd Chaitra, 2081, with the possibility of an extension until the 12th Chaitra, 2081, if the issue remains partially subscribed.
The company’s total capital stands at Rs. 60 Crores, with 30% (or 1,800,000 unit shares valued at Rs. 18 Crores) slated for future release to the public. Among this public offering, 10% of the shares, equating to 180,000 unit shares, have previously been allocated for Nepalese citizens employed overseas.
From the total 1,800,000 units, 90,000 (which is 5% of 1,800,000) have been earmarked for mutual funds, and 54,000 (or 3% of 1,800,000) units have been reserved for company employees. The leftover 1,476,000 units will be available for the general public, with the issue commencing on 27th Falgun, 2081.
Prabhu Capital Limited has been designated as the issue manager. Applications can be submitted for a minimum of 10 units and a cap of 10,000 units.
CARE Ratings Nepal Limited (CRNL) has revalidated the ‘CARE-NP BB- (Is)’ rating for Om Megashree Pharmaceuticals Limited (OMPL), signaling a moderate risk of default regarding timely financial commitments. Furthermore, CRNL has reaffirmed the ‘CARE-NP BB-’ rating for OMPL’s long-term bank facilities along with a ‘CARE-NP A4’ rating for its short-term bank arrangements
